FDA Inspection 1190311 — Mid-South Transplant Foundation

Mid-South Transplant Foundation — FEI 3003741970

The FDA completed an inspection of Mid-South Transplant Foundation on October 26, 2022 in Cordova, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 26, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cordova, TN (United States)